Joint Development Technology Agreements: Essential Terms, Issues That Arise, Pitfalls to Avoid
Recording of a 90-minute CLE video webinar with Q&A
This CLE webinar will guide corporate and technology counsel in evaluating the benefits and risks of technology collaboration and joint development agreements (JDAs). The panel will discuss structuring essential terms of these agreements, current trends, legal issues that arise with these arrangements, and strategies to avoid common contracting pitfalls.
Outline
- Overview: collaboration agreements and JDAs
- Preliminary considerations
- Key provisions
- Parties to the agreement
- Conduct of the collaboration
- Statements of work
- Project governance
- General performance standards
- Subcontracting
- Intellectual property
- Ownership
- Licensing
- Parties' rights in the IP after termination of the collaboration
- Confidentiality
- Terms of the agreement
- Other key terms
Benefits
The panel will review these and other key issues:
- What considerations should counsel keep in mind when negotiating technology JDAs?
- What issues must be addressed by the JDA regarding IP ownership?
- How should other key terms regarding statements of work, project governance, and standards of performance be structured?
- What are other important terms to consider in these agreements?
Faculty
Judith A. Hasko
Partner, Vice Chair Healthcare & Life Sciences Practice
Latham & Watkins
Ms. Hasko advises life sciences companies and investors on a wide range of technology-based commercial matters. She... | Read More
Ms. Hasko advises life sciences companies and investors on a wide range of technology-based commercial matters. She represents companies developing biotechnology, pharmaceutical, medical device and diagnostic products, and their investors on matters, including licensing and corporate partnering, joint ventures, co-promotion arrangements, manufacturing and distribution agreements, asset purchases, and royalty stream purchases and sales. Ms. Hasko brings complementary business and scientific perspectives to her legal representations. She is a Certified Licensing Professional (CLP), and a member of the Patent Bar. Ms. Hasko has co-authored several scientific publications and frequently lectures on life sciences commercial topics in both industry and academic settings, including at Berkeley Law and Stanford University.
CloseAmy L. Toro
Partner
Covington & Burling
Ms. Toro advises both pharmaceutical and biotechnology companies regarding biologics, pharmaceuticals and devices,... | Read More
Ms. Toro advises both pharmaceutical and biotechnology companies regarding biologics, pharmaceuticals and devices, including in the digital health space. She works on all types of life sciences transactions, including major collaborations, licensing arrangements, clinical trial agreements, supply and distribution agreements, product development funding deals, and joint ventures and a variety of commercial agreements. Ms. Toro also works with her mergers and acquisition colleagues on product divestitures and asset transfers.
Close